Related Experiment Video
Updated: Jul 12, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
[Botulism and dysphagia].
Laura Davison Mangilli1, Claudia Regina Furquim de Andrade
1Programa de Pós-Graduação em Ciencias da Reabilitação, Faculdade de Medicina, Universidade de São Paulo, Brazil. davisonmangilli@yahoo.com.br
Speech therapy effectively treated dysphagia in a botulism patient by improving orofacial function and restoring swallowing ability. This intervention enabled the patient to regain adequate orofacial myofunctional system functionality.
Area of Science:
- Neurology
- Speech-Language Pathology
Background:
- Botulism is a severe neuroparalytic illness caused by Clostridium botulinum toxin.
- The toxin induces flaccid paralysis by inhibiting acetylcholine release at the neuromuscular junction.
Observation:
- A botulism patient presented with severe dysphagia, difficulty swallowing saliva, and impaired orofacial myofunctional system (OMS) function.
- Clinical observations included altered OMS mobility, tonicity, and sensibility, reduced laryngeal movement, and absent swallowing reflex.
Findings:
- Speech therapy interventions focused on OMS stimulation and swallowing rehabilitation.
- The patient showed improved OMS function, laryngeal elevation, and restored swallowing function without assistance.
- Vocal quality approached normal parameters, with mild hypernasality and pneumophonoarticulatory incoordination.
Implications:
- Speech therapy is an effective treatment for dysphagia in botulism patients.
- Restoration of orofacial myofunctional system function is achievable through targeted speech therapy.
Related Concept Videos
Botulism
Diphtheria
Pyloric Obstruction
Esophageal Achalasia
Tetanus
Intestinal Obstruction II: Pathophysiology

